{"disease":{"id":"disease-acceptance","name":"disease acceptance"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06103903","title":"Measure of Acceptance of chRonic Visible sKin conditionS","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"University Hospital, Tours","has_results":false},{"nct_id":"NCT07078357","title":"Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT06124131","title":"Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Tulane University","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}